Trial intelligence / Profile preview

Bromelin for acute irritative cough

NCT01356693Phase 4Unknown

Sponsor
Universidade Federal de Pernambuco
Start
Jun 2011
Primary completion
Nov 2011
Modality
Replacement Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bromelain in cough and common cold (2 arms), sponsored by Universidade Federal de Pernambuco. Primary endpoint: Change in score in a cough evaluation questionnaire. Status: unknown.

02

Drugs

bromelain
03

Conditions

coughcommon cold

Beyond the preview

Go deeper on NCT01356693.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01356693.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call